SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Corixa [CRXA] - cancer vaccines -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (46)2/14/2001 4:22:51 PM
From: Micawber  Read Replies (1) | Respond to of 222
 
The fund manager also recommends the smaller Enzon (ENZN: news, msgs) , Tanox (TNOX: news, msgs) , Corixa (CRXA: news, msgs) , Praecis (PRCS: news, msgs) , Aviron (AVIR: news, msgs) and Imclone (IMCL: news, msgs) .

www2.marketwatch.com



To: nigel bates who wrote (46)3/16/2001 2:12:58 AM
From: Spekulatius  Respond to of 222
 
Presentation on CRXA's website:
shareholder.com
When is the FDA review for Bexxar due?